Prescription drug · ANDA
Flecainide Acetate (flecainide acetate tablet) NDC 51407-020
Flecainide acetate 150 mg/1 · Tablet · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-020-01 | 51407002001 | 100 TABLET in 1 BOTTLE (51407-020-01)Marketed from Jan 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Flecainide Acetate
- Generic name (nonproprietary)
- flecainide acetate tablet
- Active ingredients
- Flecainide acetate — 150 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075882
- Marketing start
- Listing expires
- Identifiers
- Product ID 51407-020_3e665020-7874-2ae3-e063-6394a90ac9c7SPL ID 3e665020-7874-2ae3-e063-6394a90ac9c7SPL set ID 74355cd2-b50e-0dc2-e053-2a91aa0aa164RxCUI 886662, 886666, 886671UNII M8U465Q1WQ
- Pharmacologic class
- Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407002001followed by a unit qualifier and the quantityPackage 51407-0020-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE In patients without structural heart disease, Flecainide Acetate Tablets USP are indicated for the prevention of: paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms Flecainide Acetate Tablets USP are also indicated for the prevention of: documented ventricular arrhythmias, such as sustained ventricular tachycardia ( sustained VT), that in the judgment of the physician are life-threatening. Use of Fleca…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 075882
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Flecainide Acetate | Flecainide acetate 100 mg/1 | TabletOral | A-S Medication Solutions | 50090-2968 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 50 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-018 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 100 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-019 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 150 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-1762 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 50 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-1760 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 100 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-1761 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 50 mg/1 | TabletOral | Proficient Rx LP | 82804-155 |
| Flecainide Acetate | Flecainide acetate 50 mg/1 | TabletOral | A-S Medication Solutions | 50090-6035 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 100 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-381 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 50 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-380 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 150 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-382 |
| Flecainide Acetate | Flecainide acetate 50 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1487 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 50 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-9184 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 100 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-1945 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 50 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-1946 |
| Flecainide Acetateflecainide acetate tablet | Flecainide acetate 150 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-1981 |